TYB
FDA Approves New Therapy For Advanced Breast Cancer
Tyler Durden's Photo
by Tyler Durden
Sunday, Sep 28, 2025 - 01:00 AM
Authored by Zachary Stieber via The Epoch Times (emphasis ours),
The Food and Drug Administration on Sept. 25 approved a new therapy for advanced breast cancer, based on data from a phase 3 clinical trial.
Eli Lilly's headquarters in Indianapolis, Ind., in an undated file photograph. Scott Olson/Getty Images
Regulators said in a statement that they approved imlunestrant, also known as Inluriyo, from Eli Lilly.
The therapy, an estrogen receptor antagonist, is cleared for adults who have advanced or metastatic breast cancer with estrogen receptor-1 mutations.
https://www.zerohedge.com/medical/fda-approves-new-therapy-advanced-breast-cancer